Effects of surotomycin on Clostridium difficile viability and toxin production in vitro.

Abstract excerpt

The increasing incidence and severity of infection by Clostridium difficile have stimulated attempts to develop new antimicrobial therapies. We report here the relative abilities of two antibiotics (metronidazole and vancomycin) in current use for treating C. difficile infection and of a third antimicrobial, surotomycin, to kill C. difficile cells at various stages of development and to inhibit the production of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacterial Toxins
• Share to Clostridioides difficile